All the news Showing 5 of 5 articles from: Treatment in kidney dialysisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Glecaprevir/pibrentasvir effective for people with hepatitis C and severe kidney disease Liz Highleyman / 22 December 2016 A two-drug pangenotypic regimen combining AbbVie's glecaprevir and pibrentasvir demonstrated a high sustained response rate for people with chronic hepatitis C who have severe kidney impairment, according to results from the EXPEDITION-4 study ... Curing hepatitis C may help reduce kidney disease progression Liz Highleyman / 20 December 2016 People who achieved sustained virological response to interferon-based hepatitis C treatment experienced significantly less decline in kidney function, especially if they had liver cirrhosis, according to study findings presented at the 2016 AASLD ... Sofosbuvir-based treatment safe and effective in advanced kidney disease Keith Alcorn / 05 May 2015 Sofosbuvir-based direct-acting antiviral therapy for hepatitis C can be used safely and effectively in people with very advanced kidney disease, including people on dialysis, according to the findings of the HCV-TARGET international cohort ... Merck's grazoprevir/elbasvir combo cures 99% of hepatitis C in chronic kidney disease Keith Alcorn / 29 April 2015 The once-daily combination of grazoprevir and elbasvir cured hepatitis C in 99% of people with advanced chronic kidney disease, researchers reported at the International Liver Congress last week in Vienna, Austria. The findings ... Chronic hepatitis C infection more than doubles the risk of kidney disease for people with HIV Michael Carter / 18 July 2012 A detectable hepatitis C viral load is associated with an increased risk of chronic kidney disease for people with HIV, European investigators report in the online edition of AIDS. Patients with ongoing ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive